March 05, 2015 11:32 AM ET

Biotechnology

Company Overview of ImmunoGenes AG

Company Overview

ImmunoGenes AG, a biopharmaceutical company, generates transgenic animals for the production of polyclonal and monoclonal antibodies. Its transgenic FcRn technology genetically alters animals and enhances the antibody production, as well as decreases the time of harvest. The company was founded in 2007 and is based in Baar, Switzerland.

Dorfstrasse 38

Baar,  6340

Switzerland

Founded in 2007

Key Executives for ImmunoGenes AG

Co-founder, Vice-Chairman, and Chief Executive Officer
Executive Chairman
Age: 56
Chief Financial Advisor and Director
Chief Scientific Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
CT Atlantic Ltd. Europe
MAST Biosurgery AG Europe
AmVac AG Europe
Epithelix SàRL Europe
BioFocus DPI AG Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ImmunoGenes AG, please visit www.immunogenes.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.